Invention Grant
- Patent Title: Antagonistic DR3 ligands
- Patent Title (中): 拮抗性DR3配体
-
Application No.: US13974275Application Date: 2013-08-23
-
Publication No.: US08765130B2Publication Date: 2014-07-01
- Inventor: Mette Dahl Andersen , Peder Lisby Noerby , Kristian Kjaergaard , Susanne Nedergaard Grell , Albrecht Gruhler , Jens Buchardt , Henrik Sune Andersen , Soeren Padkjaer , Jesper Kastrup , Katarina Haakansson , Lars Hornum , Birgitte Friedrichsen , Dorrit Baunsgaard
- Applicant: Novo Nordisk A/S
- Applicant Address: DK Bagsvaerd
- Assignee: Novo Nordisk A/S
- Current Assignee: Novo Nordisk A/S
- Current Assignee Address: DK Bagsvaerd
- Agent Michael J. Brignati
- Priority: EP11156416 20110301
- Main IPC: A61K39/395
- IPC: A61K39/395 ; C07K16/28 ; C07K14/705 ; A61K39/00
Abstract:
The present invention relates to treatment of inflammatory diseases. In particular, the present invention relates to antagonistic DR3 ligands useful for treating inflammatory diseases.
Public/Granted literature
- US20130336984A1 ANTAGONISTIC DR3 LIGANDS Public/Granted day:2013-12-19
Information query
